Radiometal labeling of immunoproteins: covalent linkage of 2-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid ligands to immunoglobulin.

A study was made of the covalent attachment of the bifunctional 2-(4-isothiocyanatobenzyl)diethylenetriaminetetraacetic acid family of chelate ligands to proteins for the purpose of labeling monoclonal antibodies with radiometals. The parameters and the chemical variables examined included pH, reaction period, temperature, and ligand and protein concentrations. It is shown that these variables, with the exception of protein concentration, have significant effects on the rate of protein conjugation. Conjugation of three monoclonal antibodies and human IgG under identical conditions showed only 17% variation. Finally, the effect of the concentration of conjugated IgG on radiolabeling yield was studied.

[1]  T. Waldmann,et al.  Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity. , 1989, Cancer research.

[2]  D. E. Simpson,et al.  Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studies , 1986 .

[3]  M. Hawthorne,et al.  Synthesis and antibody-labeling studies with the p-isothiocyanatobenzene derivatives of 1,2-dicarba-closo-dodecarborane(12) and the dodecahydro-7,8-dicarbanido-undecaborate(-1) ion for neutron-capture therapy of human cancer. Crystal and molecular structure of Cs+[nido-7-(p-C6H4NCS)-9-I-7,8-C2B9H11] , 1985 .

[4]  C. Meares,et al.  Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions. , 1984, Analytical Biochemistry.

[5]  T. Waldmann,et al.  Characterization of the human receptor for T-cell growth factor. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Reba,et al.  Optimization of the DTPA mixed-anhydride reaction with antibodies at low concentration. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  R. L. Childs,et al.  The preparation and labeling of DTPA-coupled albumin. , 1982, The International journal of applied radiation and isotopes.

[8]  D. Scheinberg,et al.  Tumor imaging with radioactive metal chelates conjugated to monoclonal antibodies. , 1982, Science.

[9]  D. Scheinberg,et al.  Leukemic cell targeting and therapy by monoclonal antibody in a mouse model system. , 1982, Cancer research.

[10]  P. Hand,et al.  A spectrum of monoclonal antibodies reactive with human mammary tumor cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Reba,et al.  Synthesis, plasma clearance, and in vitro stability of protein containing a conjugated indium-111 chelate , 1980 .

[12]  E. Kim,et al.  Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. , 1980, Cancer research.

[13]  C. Meares,et al.  A new route to "bifunctional" chelating agents: conversion of amino acids to analogs of ethylenedinitrilotetraacetic acid. , 1979, Analytical biochemistry.

[14]  G. Krejcarek,et al.  Covalent attachment of chelating groups to macromolecules. , 1977, Biochemical and biophysical research communications.

[15]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[16]  D. Satchell,et al.  Acylation by ketens and isocyanates. A mechanistic comparison , 1975 .

[17]  K. Kraus,et al.  ION EXCHANGE PROCEDURES. I. CATION EXCHANGE IN CONCENTRATED HC1 AND HCLO4 SOLUTIONS. , 1964, Journal of chromatography.